Green-VIII Inj. Lyophilized Powder for Solution for Injection (IV)

Nazione: Filippine

Lingua: inglese

Fonte: FDA (Food And Drug Administration)

Principio attivo:

Human Coagulation Factor VIII

Commercializzato da:

Vizcarra Pharmaceutical, Incorporated; Distributor: Vizcarra Pharmaceutical, Incorporated

INN (Nome Internazionale):

Human Coagulation Factor VIII

Dosaggio:

250 IU (25 IU/mL) Lyophilized Powder for Solution for Injection (IV)

Forma farmaceutica:

Lyophilized Powder for Solution for Injection (IV)

Confezione:

Each box contains Types I glass viak enclosed with chlorobutyl rubber stopper, crimped with aluminum seal and light blue flip-off (powder) Type I glass vial enclosed with chlorobutyl rubber stopper, crimped with aluminum seal and red- flip-off cap (10 mL Waer for Injection as diluent), Each box contains Types I glass viak enclosed with chlorobutyl rubber stopper, crimped with aluminum seal and light blue flip-of

Prodotto da:

Green Cross Corp., Korea

Dettagli prodotto:

250 IU (25 IU/mL) Lyophilized Powder for Solution for Injection (IV)

Data dell'autorizzazione:

2021-07-26